YOLFTbeta
60

Lionco Pharm Grp Co Ltd

603669 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

5.36CNY-0.24 (-4.29%)

Price History

Full chart

Market Stats

Previous Close5.60
Open5.61
Day Range5.31 – 5.63
52-Week Range4.01 – 8.40
Volume13.98M
Market Cap4.51B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.19
Dividend Yield0.00%
Beta0.24
50-Day Avg5.64
200-Day Avg5.00

About

Lionco Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products and medical services in China. It offers chemical and prescription drugs for nutrition, antimicrobial, antiviral, digestive, cardiovascular, cerebrovascular, detoxification, anti-tumor, anti-infective drugs, and other applications. Lionco Pharmaceutical Group Co.,Ltd. was founded in 2003 and is based in Shannan, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Jun Ke Zhang
  • Employees284
  • HeadquartersNo. 20, National Highway 349, Shannan, China, 856100, China
  • Websitehttps://www.lingkang.com.cn

Leadership

  • Mr. Jun Ke ZhangAccounting Supervisor & Financial Director · b. 1986
  • Mr. Xiao Gang TaoGM & Director · b. 1976
  • Mr. Li Ming LiuDeputy GM & Director · b. 1975
  • Mr. Guo Ping SuiVP & Board Secretary · b. 1973

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue271.55M468.28M494.25M576.40M550.64M478.59M1.01B1.67B1.64B1.00B740.33M289.26M196.83M379.78M322.48M
Growth (%)-+72.45%+5.54%+16.62%-4.47%-13.09%+110.01%+66.10%-2.06%-38.78%-26.04%-60.93%-31.95%+92.95%-15.09%
Cost of Revenue149.60M181.28M202.63M225.94M220.16M203.23M200.95M204.11M227.44M165.49M155.71M94.53M109.88M206.52M181.52M
Gross Profit121.95M287.00M291.61M350.46M330.49M275.36M804.13M1.47B1.41B835.51M584.62M194.74M86.96M173.26M140.97M
Gross Margin44.91%61.29%59.00%60.80%60.02%57.54%80.01%87.77%86.09%83.47%78.97%67.32%44.18%45.62%43.71%
Operating Expense56.55M159.78M161.62M186.56M158.13M146.84M622.19M1.26B1.18B654.76M513.49M383.41M235.94M302.03M234.23M
Operating Income65.40M127.22M130.00M163.90M172.35M128.52M181.94M209.01M222.63M180.75M71.13M-188.68M-148.98M-128.77M-93.26M
Operating Margin24.08%27.17%26.30%28.44%31.30%26.85%18.10%12.52%13.62%18.06%9.61%-65.23%-75.69%-33.91%-28.92%
EBITDA63.29M142.61M163.08M209.76M205.70M204.94M209.78M236.12M272.45M228.41M125.59M-140.18M-103.11M-71.44M-139.39M
EBITDA Margin23.31%30.45%33.00%36.39%37.36%42.82%20.87%14.14%16.66%22.82%16.96%-48.46%-52.38%-18.81%-43.22%
Net Income55.75M95.17M114.80M149.86M149.69M153.93M161.01M182.70M201.59M160.07M65.90M-195.86M-151.50M-130.76M-193.24M
Net Income Margin20.53%20.32%23.23%26.00%27.19%32.16%16.02%10.94%12.33%15.99%8.90%-67.71%-76.97%-34.43%-59.92%
R&D-42.76M42.98M36.77M38.58M29.34M47.40M24.30M38.04M20.36M22.77M31.63M29.12M30.37M12.70M
R&D as % of Total Revenue-9.13%8.70%6.38%7.01%6.13%4.72%1.46%2.33%2.03%3.08%10.93%14.80%8.00%3.94%
Interest Expense-100.20K125.39K330.30K4.88M457.82K147.37K2.22M13.98M11.59M15.70M5.95M3.79M27.44M21.20M
Interest Expense % of Total Revenue-0.02%0.03%0.06%0.89%0.10%0.01%0.13%0.85%1.16%2.12%2.06%1.93%7.23%6.57%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets244.38M364.89M582.12M559.83M1.34B1.34B1.65B2.07B1.91B2.72B2.51B1.86B1.62B1.26B1.11B
Total Liabilities115.83M128.67M231.09M185.70M223.98M174.57M352.40M689.97M599.60M1.24B1.06B720.32M693.52M485.57M486.50M
Total Equity128.55M236.22M351.02M374.13M1.12B1.17B1.30B1.38B1.31B1.48B1.46B1.14B931.04M769.76M620.28M
Cash48.47M61.01M151.30M81.61M158.66M220.06M312.81M711.44M510.99M1.57B986.94M575.76M343.42M254.09M155.51M
Total Debt----50.00M52.84M70.38M395.00M250.20M914.66M949.22M619.97M565.61M262.07M-
Net Debt-48.47M-61.01M-151.30M-81.61M-108.66M-167.21M-242.43M-316.44M-260.79M-652.32M-37.72M44.21M222.19M7.98M-

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow98.23M142.61M160.77M181.50M98.88M182.27M189.01M185.87M235.61M126.81M128.50M-66.36M-37.87M-110.89M-132.87M
Investing Cash Flow-49.29M-107.72M-115.13M-90.19M-660.73M34.21M-65.07M-75.17M-11.82M127.85M-432.85M131.54M-51.90M365.79M-
Financing Cash Flow-20.64M-32.45M--129.94M645.99M-154.63M-31.23M284.85M-427.93M811.92M-278.89M-473.35M-158.99M-322.08M-
Capital Expenditure24.74M109.64M103.97M116.70M70.10M88.94M86.57M173.70M10.87M61.95M54.82M42.84M23.13M8.85M2.68M
Free Cash Flow73.49M32.97M56.81M64.80M28.77M93.34M102.44M12.18M224.74M64.86M73.69M-109.20M-61.01M-119.74M-135.55M
Dividends Paid28.83K--126.94M111.96M104.53M31.20M106.02M265.72M101.92M159.21M71.76M8.08M5.73M6.59M
FCF to OCF74.82%23.12%35.33%35.70%29.10%51.21%54.20%6.55%95.39%51.15%57.34%164.56%161.07%107.98%102.02%
Dividend Paid to FCF0.04%--195.89%389.09%111.99%30.46%870.59%118.24%157.13%216.06%-65.72%-13.25%-4.79%-4.86%

Earnings

Report DateAug 19, 2015Oct 28, 2015Dec 31, 2015Apr 15, 2016Aug 20, 2016Oct 27, 2016Dec 31, 2016Apr 14, 2017Aug 18, 2017Oct 28, 2017Mar 23, 2018Mar 31, 2018Aug 11, 2018Oct 27, 2018Dec 31, 2018Apr 27, 2019Sep 1, 2019Oct 26, 2019Dec 31, 2019Apr 22, 2020Aug 7, 2020Oct 29, 2020Dec 31, 2020Apr 16, 2021Aug 20, 2021Oct 29, 2021Dec 31, 2021Apr 29, 2022Aug 26, 2022Oct 28, 2022Dec 31, 2022Apr 21, 2023
EPS Estimate--------------------------------
EPS Actual0.060.040.070.040.070.040.070.040.040.050.090.050.050.140.020.050.100.060.070.090.010.110.010.050.050.01-0.020.030.02-0.16-0.18-0.16
Surprise--------------------------------
TimingAfter-hoursAfter-hours-After-hoursPre-marketAfter-hours-Pre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hours-After-hoursPre-marketAfter-hours-After-hoursPre-marketPre-market-Pre-marketPre-marketAfter-hours-After-hoursPre-marketAfter-hours-Pre-market

Key Statistics & Ratios

Market Cap4.51B
Enterprise Value4.44B
Trailing P/E0.00
Forward P/E0.00
Price / Sales11.04
Price / Book6.69
EPS-0.19
Book Value0.912
Revenue (TTM)408.33M
Gross Profit (TTM)213.06M
EBITDA-29.45M
Profit Margin-33.40%
Operating Margin13.82%
Return on Equity-19.83%
Return on Assets-2.93%
Shares Outstanding712.36M
Shares Float266.56M
Beta0.24
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.10Jul 5, 2022
20211×
0.20May 31, 2021
20201×
0.20May 26, 2020
20192×
0.14Oct 10, 20190.32Jun 6, 2019
20181×
0.20May 10, 2018
20171×
0.04Jun 7, 2017
20161×
0.15Jun 15, 2016

Stock Splits

  • May 26, 2020188394:134567
  • Jun 6, 20197:5
  • May 10, 2018188394:134567